N

Nuoncology Labs Inc
OTC:NLAB

Watchlist Manager
Nuoncology Labs Inc
OTC:NLAB
Watchlist
Price: 297 USD Market Closed
Updated: May 20, 2024

Operating Margin
Nuoncology Labs Inc

0%
Current
0%
Average
6.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-29.2k
/
Revenue
0

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
US
Nuoncology Labs Inc
OTC:NLAB
29.3B USD N/A
CA
Advance Lithium Corp
XTSX:AALI
509.5B CAD N/A
US
Gould Investors LP
OTC:GDVTZ
303.5B USD N/A
US
Carson Energy Development Corp
OTC:CDVM
270.6B USD
-340%
NL
Nepi Rockcastle NV
JSE:NRP
76.1B Zac
59%
US
Liberty Bancshares Inc
OTC:LBSI
55.5B USD N/A
US
Ergo Science Corp
OTC:ERGN
55.2B USD
-21%
US
HK Graphene Technology Corp
OTC:HKGT
53.9B USD N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
743.3T IDR
54%
US
GE Vernova LLC
NYSE:GEV
44.6B USD
-1%
US
Coupang Inc
F:788
37.5B EUR
2%
N
Nuoncology Labs Inc
OTC:NLAB
Country US
Market Cap 29.3B USD
Operating Margin N/A
A
Advance Lithium Corp
XTSX:AALI
Country CA
Market Cap 509.5B CAD
Operating Margin N/A
G
Gould Investors LP
OTC:GDVTZ
Country US
Market Cap 303.5B USD
Operating Margin N/A
C
Carson Energy Development Corp
OTC:CDVM
Country US
Market Cap 270.6B USD
Operating Margin
-340%
N
Nepi Rockcastle NV
JSE:NRP
Country NL
Market Cap 76.1B Zac
Operating Margin
59%
Liberty Bancshares Inc
OTC:LBSI
Country US
Market Cap 55.5B USD
Operating Margin N/A
Ergo Science Corp
OTC:ERGN
Country US
Market Cap 55.2B USD
Operating Margin
-21%
H
HK Graphene Technology Corp
OTC:HKGT
Country US
Market Cap 53.9B USD
Operating Margin N/A
Amman Mineral Internasional Tbk PT
IDX:AMMN
Country ID
Market Cap 743.3T IDR
Operating Margin
54%
G
GE Vernova LLC
NYSE:GEV
Country US
Market Cap 44.6B USD
Operating Margin
-1%
Coupang Inc
F:788
Country US
Market Cap 37.5B EUR
Operating Margin
2%

Profitability Report

View the profitability report to see the full profitability analysis for Nuoncology Labs Inc.

Full Profitability Report

See Also

Summary
NLAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
NLAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NLAB stock valuation using valuation multiples.
Wall Street Estimates
NLAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NLAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-29.2k
/
Revenue
0
What is the Operating Margin of Nuoncology Labs Inc?

Based on Nuoncology Labs Inc's most recent financial statements, the company has Operating Margin of 0%.

ALPHA SPREAD
Join more than 138,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.